ArticleScientific reports2017

MiR-200c regulates tumor growth and chemosensitivity to cisplatin in osteosarcoma by targeting AKT2.

Yang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.